Breast Surgery Research

Evidence article

Breast Augmentation for Congenital Asymmetry: Evidence-Based Planning Limits

Breast augmentation congenital asymmetry evidence explains why volume, breast base, fold height, nipple position and chest-wall anatomy all matter—and why surgery aims for improved balance, not exact symmetry.

Evidence article

Drains vs No Drains in Breast Implant Surgery: How Practice Changed

Drains vs no drains breast augmentation evidence explained: what trials and reviews show about seroma, haematoma, infection and procedure-specific decision-making.

Evidence article

ERAS in Aesthetic Breast Surgery: The Evidence Behind Faster Recovery Pathways

ERAS aesthetic breast surgery evidence explained: preparation, anaesthesia, pain relief, nausea prevention, early intake, mobilisation and the limits of recovery claims.

Evidence article

Outpatient Breast Augmentation and Anesthesia: How Same-Day Pathways Developed

Outpatient breast augmentation anesthesia evidence explained: patient selection, general and regional techniques, monitored recovery, same-day discharge and safety limits.

Evidence article

Early Mobilisation and Return to Daily Activities After Aesthetic Breast Surgery

Return to activity after breast augmentation research explained: early movement, daily tasks, work, driving and sport, with evidence limits and individual variation.

Evidence article

Breast Implant Rippling and Wrinkling: Filler, Coverage and Pocket Variables

Breast implant rippling evidence explained: filler, tissue coverage, pocket variables, surface, assessment and the limits of revision claims.

Evidence article

Breast Implant Malposition: Bottoming Out, Lateral Displacement and Double Bubble in the Literature

Breast implant malposition evidence explained: bottoming out, lateral displacement and double bubble, their anatomy, study limits and revision discussions.

Evidence article

Treating Capsular Contracture After Breast Augmentation: What Revision Studies Show

Capsular contracture treatment evidence: capsulectomy, capsulotomy, implant exchange, plane change, recurrence and limits of revision studies.

Evidence article

Ultrasound and MRI for Silicone Implant Rupture: How Screening Guidance Changed

Ultrasound MRI breast implant rupture screening evidence explained: current FDA timing, screening versus diagnosis and why symptoms require assessment.

Evidence article

Mammography After Breast Augmentation: Imaging Technique, Safety and Evidence

Mammography with breast implants evidence explained: implant-displaced views, screening continuity, facility communication and the difference from rupture monitoring.

Evidence article

SCC and Other Rare Lymphomas Around Breast Implants: What Is Known

SCC breast implant capsule evidence explained: rare reports, uncertainty, symptoms that need assessment and why surveillance remains essential.

Evidence article

How Long Do Breast Implants Last? Longevity, Reoperation and Monitoring Evidence

Breast implant longevity evidence explained: why implants are not lifetime devices, what reoperation data mean and how monitoring guides individual decisions.

Evidence article

Breast-Q and Patient-Reported Outcomes: How Breast Augmentation Success Is Measured

BREAST-Q breast augmentation outcomes evidence explained: how validated patient-reported measures separate satisfaction, psychosocial, sexual and physical well-being.

Evidence article

Satisfaction and Quality of Life After Breast Augmentation: What Meta-Analyses Show

Breast augmentation satisfaction quality of life evidence explained: what meta-analyses show, why follow-up differs and why group averages cannot predict an individual result.

Evidence article

Breast Implant Registries and Long-Term Device Surveillance

Breast implant registry long-term surveillance evidence explained: registries, post-approval studies, device records, follow-up completeness and safer evidence over time.

Evidence article

Informed Consent in Breast Implant Surgery: How Risk Communication Has Changed

Breast implant informed consent evidence explained: device-specific risks, patient decision checklists, uncertainty and long-term follow-up discussions.

Evidence article

Transumbilical Breast Augmentation: Why the Technique Is Historically Interesting but Limited

Transumbilical breast augmentation evidence explained: review TUBA history, classic saline-only constraints, implant-selection limits and its selective current relevance.

Evidence article

Breast Pocket Irrigation and Implant Immersion: Evidence, Uncertainty and Current Practice

Breast implant pocket irrigation evidence compared: antibiotic, povidone-iodine, chlorhexidine, saline and implant immersion, with the limits of current research.

Evidence article

Hemostasis and Hematoma Prevention in Breast Augmentation

Hematoma prevention breast augmentation evidence explained: surgical dissection, haemostasis, risk factors, recognition and the limits of technique comparisons.

Evidence article

Multimodal Analgesia and Opioid-Sparing Recovery After Breast Surgery

Multimodal analgesia breast augmentation recovery evidence explained: non-opioid medicines, regional blocks, opioid-sparing care and the limits of current studies.

Evidence article

Animation Deformity and the Pectoral Muscle: How Pocket Choice Affects Movement

Animation deformity breast implant evidence explained: pectoral muscle contraction, subpectoral and dual-plane pockets, assessment, revision options and study limits.

Evidence article

Capsular Contracture: Biology, Risk Factors and Why Prevention Evidence Is Difficult

Capsular contracture risk factors evidence explained: capsule biology, biofilm theory, infection, hematoma, pocket variables and why prevention studies are limited.

Evidence article

Breast Implant Rupture: From Clinical Symptoms to Silent Rupture Detection

Breast implant rupture research explained: saline deflation, silent silicone rupture, intracapsular and extracapsular findings, imaging and evidence limits.

Evidence article

BIA-ALCL and Breast Implants: How a Rare Signal Changed Implant Safety Practice

BIA-ALCL breast implant surface evidence explained: rare lymphoma, textured-surface association, symptoms, BIOCELL recall, investigation and risk limitations.

Evidence article

Breast Implant Illness and Systemic Symptoms: Evidence, Uncertainty and Patient Assessment

Breast implant illness symptoms evidence review: reported systemic symptoms, research limits, differential assessment, explantation uncertainty and shared decisions.

Evidence article

Breast Implant Dimensions, Base Width and CC: What the Measurements Mean Clinically

Breast implant dimensions base width cc evidence explained: learn why volume is not cup size and how width, projection, shape and tissue coverage interact in clinical planning.

Evidence article

Breast Augmentation Before Silicone Implants: Materials and Methods from 1950 to 1961

Breast augmentation before silicone implants relied on grafts, injections and porous or solid materials. This evidence-based history explains why those approaches were abandoned and why surgeons sought a contained implant.

Evidence article

1962 and the First Silicone Breast Implant: The Cronin–Gerow Milestone

The 1962 first silicone breast implant by Thomas Cronin and Frank Gerow changed breast augmentation by placing silicone gel inside a contained shell. Learn what is documented about the device, Timmie Jean Lindsey’s operation, the 1963 report and the limits of the “natural feel” story.

Evidence article

The Early Saline Breast Implant: Why Inflatable Devices Appeared

The early saline breast implant history is a story of engineering around a practical surgical problem: how to place a breast prosthesis through a smaller incision. Inflatable devices offered a clever solution, but early shells, seams and valves introduced new trade-offs beside silicone gel implants.

Evidence article

Second-Generation Breast Implants in the 1970s: Thin Shells and Low-Viscosity Gel

1970s breast implant technology replaced thicker shells and firmer gel with thinner, more flexible shells and softer, low-viscosity silicone gel. The design felt more natural, but later evidence linked this generation to silicone bleed-through, shell failure and difficult-to-predict shape changes.

Evidence article

Third-Generation Breast Implants in the 1980s: Shell Strength and Gel Containment

Third-generation breast implants emerged in the 1980s after concerns about rupture and silicone gel bleed in earlier devices. This evidence-based history explains multilayer shells, reinforcement, barrier layers and the limits of comparing implant generations.

Evidence article

Cohesive Gel and Anatomical Breast Implants: The Late-1980s and 1990s Shift

Cohesive gel and anatomical breast implants changed the design conversation from volume alone to gel behaviour, dimensions, orientation and the implant–tissue interface. This evidence-based history explains the late-1980s and 1990s shift without treating any shape or surface as universally suitable.

Evidence article

Breast Implants, FDA Class III Regulation and the 1992 Silicone Moratorium

The 1992 FDA breast implant moratorium was a response to an evidence gap, not a simple finding that every silicone implant was proven harmful. This evidence-based history explains Class III regulation, the restricted-access period, the research that followed and the lasting change in patient communication.

Evidence article

The 2000 Saline and 2006 Silicone Approvals: What Post-Approval Studies Added

The 2000 saline and 2006 silicone approvals were important FDA milestones, but neither was a lifetime guarantee. This evidence review explains what the approvals covered, what post-approval studies added and why follow-up quality matters.

Evidence article

Breast Implant Surface Technology in the 2010s: Smooth, Textured and Microtextured Devices

The 2010s changed how breast implant surfaces were discussed. This evidence review explains why texturing was developed, what smooth, textured and microtextured shells were intended to do, what trade-offs emerged and why current regulator information matters more than a decade label.

Evidence article

The 2019 BIOCELL Recall and the New Era of Breast Implant Safety Surveillance

The 2019 BIOCELL breast implant recall marked a major change in how breast implant safety was detected, communicated and monitored. This evidence review explains the BIA-ALCL signal, the regulator’s action, what the recall did and did not mean for other implants, and how current patients can use device records, symptom awareness and ongoing post-market evidence responsibly.

Evidence article

The 2020–2021 Breast Implant Labeling Changes: Boxed Warnings and Patient Decision Checklists

In 2020 and 2021, the FDA changed how breast implant benefits, risks, monitoring and future surgery were presented to patients. This evidence review explains the boxed warning, patient decision checklist, device card and the questions a patient should discuss before choosing an implant.

Evidence article

Breast Implant Technology and Labeling in 2024–2026: What Has Changed and What Has Not

The latest breast implant technology in 2026 is not one universal upgrade. This evidence review explains recent FDA device records, labeling updates, post-approval surveillance and the risks that still require informed consent.

Evidence article

Silicone vs Saline Breast Implants: How the Evidence Evolved

A balanced evidence review of silicone versus saline breast implants, covering filler, feel, rupture presentation, imaging, patient selection and the limits of comparative studies.

Evidence article

Round vs Anatomical Breast Implants: Design History, Rotation and Patient Selection

Round vs anatomical breast implant evidence is more nuanced than a choice between “natural” and “artificial.” This review explains design history, the limited aesthetic comparison studies, rotation, surface safety context and anatomy-led selection.

Evidence article

Breast Implant Profile and Projection: From Cup-Size Thinking to Three-Dimensional Planning

Breast implant profile and projection evidence shows why cc alone cannot predict cup size or appearance. This review explains implant footprint, projection, chest width, tissue coverage and the limits of three-dimensional planning for primary cosmetic breast augmentation.

Evidence article

The Evolution of Breast Implant Pocket Placement: Subglandular, Subpectoral and Subfascial

Breast implant pocket placement evidence has evolved from subglandular surgery toward subpectoral, dual-plane and subfascial options. This review compares intended benefits, complication profiles and patient-specific trade-offs in primary cosmetic augmentation.

Evidence article

Dual-Plane Breast Augmentation: Origins, Rationale and Current Evidence

Dual-plane breast augmentation evidence explains why surgeons combine upper-pole muscle coverage with lower-pole tissue expansion. This review traces the technique’s origins, tissue relationships, indications, trade-offs and limits of current comparative research.

Evidence article

Tuberous Breasts and Augmentation: How Planning Evolved Beyond Implant-Only Solutions

Tuberous breasts augmentation evidence shows why a narrow base, lower-pole deficiency, areolar features and asymmetry may need reshaping as well as implant volume.

Evidence article

Poland Syndrome and Congenital Chest Differences: Why Standard Implant Studies May Not Apply

Poland syndrome breast augmentation evidence is limited by wide differences in muscle, ribs, soft tissue, breast development and reconstruction goals. This review explains why standard implant studies may not predict a congenital chest reconstruction.

Evidence article

Three-Dimensional Imaging, Sizers and Shared Decision-Making in Implant Planning

3D imaging breast implant planning evidence shows that simulations, sizers and shared decision-making can clarify options and expectations, but none guarantees the final breast shape or cup size.

Evidence article

Breast Implants vs Fat Transfer: Comparative Evidence on Volume, Feel and Durability

Breast implants vs fat transfer evidence explained: compare donor fat, volume control, retention, repeat procedures, feel, durability and the limits of current comparative research.

Evidence article

Personalised Breast Augmentation: How Anatomy Became More Important Than Implant Volume

Anatomy-based breast implant planning evidence explained: how chest width, breast base, tissue coverage, skin quality, posture and goals shape implant selection.

Evidence article

Inframammary vs Periareolar Incisions: Technique History and Evidence

Inframammary vs periareolar breast augmentation evidence compared: access, scar outcomes, contamination questions, breastfeeding considerations and patient-specific trade-offs.

Evidence article

Transaxillary Endoscopic Breast Augmentation: From Remote Access to Modern Visualization

Transaxillary endoscopic breast augmentation evidence explained: trace the route from blind axillary surgery to endoscopic visualization, indications, limitations and comparative findings against inframammary access.

Evidence article

The No-Touch Technique and Keller Funnel: What the Evidence Supports

No-touch breast augmentation Keller funnel evidence explained: contamination theory, insertion funnels, reported contracture outcomes and why randomized proof is still missing.

Evidence article

The Evolution of Breast Reduction Surgery: From Large Resections to Tissue-Preserving Planning

The evolution of breast reduction surgery explained: from large resections to pedicle design, breast shape preservation, nipple viability and patient-reported outcomes.

Evidence article

The Wise Pattern and Inverted-T Breast Reduction: Why the Scar Pattern Developed

Wise pattern breast reduction evidence explained: why the inverted-T scar pattern developed, where its flexibility helps, and how its scar and wound-healing trade-offs compare with vertical approaches.

Evidence article

Vertical Scar and Lejour Breast Reduction: Development, Indications and Limitations

Vertical scar breast reduction evidence explained: Lejour technique development, skin-envelope limits, patient selection and the strengths and limits of comparative studies.